Fig. 2From: Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide studyProportion of new users who initiated with levodopa, non-ergot dopamine agonists (DA), or anticholinergics for each financial year A) stratified by age (< 65 years vs. ≥ 65 years); or B) stratified by sexBack to article page